Connect with us

Guides

University of Sciences in Philadelphia to Open Up a MBA of Medical Cannabis Education

Published

on

University of Sciences in Philadelphia to Open Up a MBA of Medical Cannabis Education

The first MBA of Medical Cannabis is now available at the University of Sciences in Philadelphia, PA. It is part of the Substance Use Disorders Institute and is focused on the pharmaceutical and health care industries. There have been countless testimonials on the benefits of cannabis for debilitating health conditions such as anxiety, depression, epilepsy, and Parkinson’s. The university has partnered with Franklin Biosciences of Denver, CO to develop the program. The same company operates Beyond/Hello dispensaries in Pennsylvania.

There has been a lot of interest in the program from current students and they expect to have a class of 15 to 20 students to start. A total of four classes will be offered online including Introduction to the Medical Cannabis Industry, Regulation of the Cannabis Industry, Cannabis Marketing and Sales, and a Project-Based course where a product or business plan will be developed. Each two-credit course costs approximately $2,000 and registration has already begun. Despite medical or adult-use marijuana laws in several states, marijuana is illegal under federal law.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.